Suppr超能文献

口腔颌面部微囊型淋巴管畸形的硬化治疗

Sclerotherapy of microcystic lymphatic malformations in oral and facial regions.

作者信息

Bai Yi, Jia Jun, Huang Xing-Xing, Alsharif Mohd Jamal, Zhao Ji-Hong, Zhao Yi-Fang

机构信息

Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Wuhan University, Wuhan, People's Republic of China.

出版信息

J Oral Maxillofac Surg. 2009 Feb;67(2):251-6. doi: 10.1016/j.joms.2008.06.046.

Abstract

PURPOSE

Lymphatic malformations (LMs) are benign vascular lesions that can cause disfigurement and functional impairment. Complete surgical resection is often difficult and intralesional injection of sclerosing agents has been proposed as an alternative to the surgery. The aim of this study was to review our experience with pingyangmycin (bleomycin A(5)) injection alone or in combination with surgery for treatment of oral and facial LMs, and to observe the histologic changes after intralesional injection of pingyangmycin.

PATIENTS AND METHODS

Seventy-nine patients who received intralesional injection of pingyangmycin for the treatment of oral and facial LMs were reviewed. There were 47 males and 32 females, at a ratio of 1 to 0.68. Age ranged from 4 months to 17 years. The sites of the lesions occurred primarily in the tongue, which was found in 37 cases, followed by cheeks in 18, involved lips in 10, parotid gland in 7, oropharynx in 5, and floor of the mouth in only 2 cases. Among them, 42 patients received pingyangmycin sclerotherapy solely, 14 patients had sclerotherapy in combination with secondary surgery, and 23 other patients had surgery with sclerotherapy. Patients had been followed up more than 6 months after the last treatment. The rating of the results was 4-graded: excellent, good, fair, and poor (based on clinical outcome). The histologic changes were observed under microscope in 14 resected specimens after the sclerotherapy.

RESULTS

Primary anatomic locations of 79 LMs involved the face in 25 cases, and the oral cavity in 54. Median number of injections received per child was 4.2 (range, 3 to 8). Among the 79 patients, 44 cases (55.7%) were graded as excellent, 23 cases (29.11%) as good, 10 cases (12.66%) as fair, and 2 cases (2.53%) as poor. There were fewer totally cured or near-normal appearance in the sole sclerotherapy group (42.86%) than in the surgery with the sclerotherapy group (73.91%; P< .05). In specimens resected after pingyangmycin injection, histologic examination showed the destructive lymphatic vessels and obvious stromal fibrosis.

CONCLUSIONS

Intralesional injection of pingyangmycin was effective for over two thirds of the children with oral and facial LMs. Perioperative sclerotherapy may improve the treatment of these malformations.

摘要

目的

淋巴管畸形(LMs)是一种良性血管病变,可导致容貌毁损和功能障碍。完全手术切除通常较为困难,瘤内注射硬化剂被提议作为手术的替代方法。本研究的目的是回顾我们单独使用平阳霉素(博来霉素A5)注射或联合手术治疗口腔颌面部淋巴管畸形的经验,并观察平阳霉素瘤内注射后的组织学变化。

患者与方法

回顾了79例接受平阳霉素瘤内注射治疗口腔颌面部淋巴管畸形的患者。其中男性47例,女性32例,男女比例为1:0.68。年龄范围为4个月至17岁。病变部位主要发生在舌部,共37例,其次为颊部18例,唇部10例,腮腺7例,口咽5例,仅2例发生于口底。其中,42例患者仅接受平阳霉素硬化治疗,14例患者硬化治疗联合二期手术,23例患者手术联合硬化治疗。患者在最后一次治疗后随访超过6个月。结果分为4级:优、良、中、差(基于临床结果)。对14例硬化治疗后切除标本进行显微镜下组织学变化观察。

结果

79例淋巴管畸形的主要解剖部位涉及面部25例,口腔54例。每个儿童接受注射的中位数为4.2次(范围3至8次)。79例患者中,44例(55.7%)评定为优,23例(29.11%)为良,10例(12.66%)为中,2例(2.53%)为差。单纯硬化治疗组完全治愈或外观接近正常的比例(42.86%)低于手术联合硬化治疗组(73.91%;P<0.05)。平阳霉素注射后切除的标本组织学检查显示淋巴管破坏及明显的间质纤维化。

结论

瘤内注射平阳霉素对超过三分之二的口腔颌面部淋巴管畸形患儿有效。围手术期硬化治疗可能改善这些畸形的治疗效果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验